Anjalee Khemlani’s Post

At the 6th meeting of the Drugs committee we discussed Portugal’s experience with drugs decriminalisation 👇

Use caution at parties this holiday season. Fentanyl is a deadly synthetic opioid that drug traffickers are mixing with other drugs like marijuana and cocaine to hook customers on the first try. You can not see, smell, or taste it. Learn more: OddsAreAlabama.org #FentanylAwareness #OddsAreAlabama #FentanylOverdose #OverdoseAwareness

Our latest policy brief analyzes the risk of this ongoing shortage of #prescriptionstimulants and how it creates a market for counterfeit #amphetamine drugs. Learn more at https://lnkd.in/en5UMt5U

Interesting explanation about the noble face of snake venom toxicity as a source of inspiration for drugs development https://lnkd.in/e8VY5kvf

Saliva identifies what drug. But still require an objective test of functions critical for safe driving. #IMMADtestsMJdui IMMAD is an objective test of peripheral retinal functions critical for safe driving. https://lnkd.in/eW4g2YkA

NARCAN - Generic Name, Drug class, Brande Name ,Precautions , How to use, Side Effects

Navigating the complex landscape of anti-obesity drugs and the ongoing battle over utilization management. As we strive for effective treatments, it's crucial to address challenges in access and utilization. Let's engage in meaningful discussions to find balanced solutions. #ObesityTreatment #HealthcareDebate #UtilizationManagement

Every day, anti-obesity medications like GLP-1's take center stage in the dynamic world of pharmacy benefits, and it's a conversation that absolutely deserves our attention. Navigating the landscape of GLP-1 coverage isn't a simple task for plans, and a one-size-fits-all approach just doesn't work. As highlighted by Adam Fein in the video below, the GLP-1 conundrum persists into 2024 and may become even more complex. #pharmacybenefits #glp1 #utilizationmanagement